NO20015662L - Oralt aktive A1-adenosinreseptorantagonister - Google Patents

Oralt aktive A1-adenosinreseptorantagonister

Info

Publication number
NO20015662L
NO20015662L NO20015662A NO20015662A NO20015662L NO 20015662 L NO20015662 L NO 20015662L NO 20015662 A NO20015662 A NO 20015662A NO 20015662 A NO20015662 A NO 20015662A NO 20015662 L NO20015662 L NO 20015662L
Authority
NO
Norway
Prior art keywords
receptor antagonists
adenosine receptor
orally active
orally
active
Prior art date
Application number
NO20015662A
Other languages
English (en)
Other versions
NO320854B1 (no
NO20015662D0 (no
Inventor
Brent K Blackburn
Chris Melville
Jeff A Zablocki
Venkata P Palle
Elfatih O Elzein
Lisa Wang
Original Assignee
Cv Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cv Therapeutics Inc filed Critical Cv Therapeutics Inc
Publication of NO20015662D0 publication Critical patent/NO20015662D0/no
Publication of NO20015662L publication Critical patent/NO20015662L/no
Publication of NO320854B1 publication Critical patent/NO320854B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/167—Purine radicals with ribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
NO20015662A 1999-05-24 2001-11-20 Heterocykliske, subsitituerte adenosinderivater, farmasoytiske preparater omfattende slike og anvendelse av derivatene for fremstilling av farmasoytiske preparater NO320854B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/317,523 US6576619B2 (en) 1999-05-24 1999-05-24 Orally active A1 adenosine receptor agonists
PCT/US2000/014036 WO2000071558A1 (en) 1999-05-24 2000-05-19 Orally active a1 adenosine receptor agonists

Publications (3)

Publication Number Publication Date
NO20015662D0 NO20015662D0 (no) 2001-11-20
NO20015662L true NO20015662L (no) 2002-01-23
NO320854B1 NO320854B1 (no) 2006-02-06

Family

ID=23234062

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015662A NO320854B1 (no) 1999-05-24 2001-11-20 Heterocykliske, subsitituerte adenosinderivater, farmasoytiske preparater omfattende slike og anvendelse av derivatene for fremstilling av farmasoytiske preparater

Country Status (19)

Country Link
US (1) US6576619B2 (no)
EP (1) EP1181302B1 (no)
JP (2) JP2003520776A (no)
KR (1) KR100537032B1 (no)
CN (1) CN1183153C (no)
AR (1) AR035909A1 (no)
AT (1) ATE250621T1 (no)
AU (1) AU760658B2 (no)
BR (1) BR0010882A (no)
CA (1) CA2375040C (no)
DE (1) DE60005507T2 (no)
ES (1) ES2206238T3 (no)
IL (2) IL146471A0 (no)
MX (1) MXPA01012038A (no)
NO (1) NO320854B1 (no)
NZ (1) NZ515580A (no)
TW (1) TW593330B (no)
WO (1) WO2000071558A1 (no)
ZA (1) ZA200109626B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL127947A0 (en) 1999-01-07 1999-11-30 Can Fite Technologies Ltd Pharmaceutical use of adenosine agonists
US6790839B2 (en) 1999-01-07 2004-09-14 Can-Fite Biopharma Ltd. Pharmaceutical administration of adenosine agonists
US7144871B2 (en) * 2002-02-19 2006-12-05 Cv Therapeutics, Inc. Partial and full agonists of A1 adenosine receptors
AU2003231777C1 (en) * 2002-04-29 2009-10-29 Supernus Pharmaceuticals, Inc. Pharmaceutical formulations with improved bioavailability
CA2536401C (en) 2003-11-04 2011-08-30 Shire Laboratories Inc. Compositions of quaternary ammonium compounds containing bioavailability enhancers
ATE493981T1 (de) 2003-11-04 2011-01-15 Supernus Pharmaceuticals Inc Einmal tägliche dosierformen von trospium
RU2009102536A (ru) 2006-06-27 2010-08-10 Биовитрум Аб (Пабл) (Se) Терапевтические соединения
US7731604B2 (en) * 2006-10-31 2010-06-08 Taylor Made Golf Company, Inc. Golf club iron head
CN101712709A (zh) * 2008-10-06 2010-05-26 中国医学科学院药物研究所 三乙酰基-3-羟基苯基腺苷及其调血脂的用途
DE102011005232A1 (de) 2011-03-08 2012-09-13 AristoCon GmbH & Co. KG Adenosin und seine Derivate zur Verwendung in der Schmerztherapie

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2460929A1 (de) 1974-12-21 1976-06-24 Boehringer Sohn Ingelheim Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung
US4364922A (en) 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
JPS57171998A (en) * 1981-04-15 1982-10-22 Fujisawa Pharmaceut Co Ltd Adenosine derivative and its salt, preparation thereof and medicinal composition containing the same
DE3138397A1 (de) 1981-09-26 1983-04-07 Hoechst Ag, 6230 Frankfurt "arzneimittel, darin enthaltene vicinale dihydroxyalkylxanthine und herstellungsverfahren fuer diese xanthinverbindungen"
US4593019A (en) 1984-10-26 1986-06-03 Warner-Lambert Company N6 -tricyclic adenosines
CA1255297A (en) 1984-10-26 1989-06-06 Bharat Trivedi N.sup.6-benzopyrano and benzothiopyrano adenosines
AU8274187A (en) 1986-10-31 1988-05-25 Warner-Lambert Company Heteroaromatic derivatives of adenosine
US4954504A (en) 1986-11-14 1990-09-04 Ciba-Geigy Corporation N9 -cyclopentyl-substituted adenine derivatives having adenosine-2 receptor stimulating activity
EP0355131B1 (en) * 1987-10-28 1996-09-04 Pro-Neuron, Inc. Acyl deoxyribonucleoside derivatives and uses thereof
US4980379A (en) 1988-06-30 1990-12-25 The University Of Virginia Use of adenosine antagonists in the treatment of bradyarrhythmias and hemodynamic depression associated with cardiopulmonary resucitation and/or cardiovascular collapse
DE8817122U1 (no) 1988-12-22 1993-02-04 Boehringer Ingelheim Kg, 6507 Ingelheim, De
AU626983B2 (en) 1989-01-31 1992-08-13 Whitby Research, Inc. N6-substituted 9-methyladenines
US5017578A (en) 1989-06-09 1991-05-21 Hoechst-Roussel Pharmaceuticals Inc. N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents
JPH06102662B2 (ja) 1989-09-01 1994-12-14 協和醗酵工業株式会社 キサンチン誘導体
DE4019892A1 (de) 1990-06-22 1992-01-02 Boehringer Ingelheim Kg Neue xanthinderivate
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
US5432164A (en) 1991-10-24 1995-07-11 Novo Nordisk A/S C2,N6 -disubstituted adenosine derivatives
DE4205306B4 (de) 1992-02-21 2005-11-24 Glüsenkamp, Karl-Heinz, Dr. Säureamide, Arzneimittel mit denselben und Verfahren zur Herstellung von Säureamiden
US5288721A (en) 1992-09-22 1994-02-22 Cell Therapeutics, Inc. Substituted epoxyalkyl xanthines
WO1994016702A1 (en) 1993-01-26 1994-08-04 Kyowa Hakko Kogyo Co., Ltd. Remedy for irregular bowel movement
AU7331094A (en) 1993-07-13 1995-02-13 United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The A3 adenosine receptor agonists
US5446046A (en) 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
GB9723566D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
GB9723590D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
CA2375040A1 (en) 2000-11-30
JP2006348040A (ja) 2006-12-28
NZ515580A (en) 2004-06-25
AU5037600A (en) 2000-12-12
ATE250621T1 (de) 2003-10-15
IL146471A (en) 2007-06-03
JP2003520776A (ja) 2003-07-08
DE60005507D1 (de) 2003-10-30
US20020091099A1 (en) 2002-07-11
ZA200109626B (en) 2004-03-10
KR20020092777A (ko) 2002-12-12
BR0010882A (pt) 2002-06-11
IL146471A0 (en) 2002-07-25
KR100537032B1 (ko) 2005-12-16
NO320854B1 (no) 2006-02-06
CA2375040C (en) 2006-02-07
AR035909A1 (es) 2004-07-28
US6576619B2 (en) 2003-06-10
DE60005507T2 (de) 2004-06-24
CN1390228A (zh) 2003-01-08
WO2000071558A1 (en) 2000-11-30
ES2206238T3 (es) 2004-05-16
MXPA01012038A (es) 2002-05-06
EP1181302B1 (en) 2003-09-24
AU760658B2 (en) 2003-05-22
TW593330B (en) 2004-06-21
CN1183153C (zh) 2005-01-05
NO20015662D0 (no) 2001-11-20
EP1181302A1 (en) 2002-02-27

Similar Documents

Publication Publication Date Title
IS5706A (is) Adenosín A3 viðtakastillar
CY2010003I1 (el) Αγωνιστες των βητα-2 αδρενεργικων υποδοχεων
PT1192169E (pt) C-pirazoles agonistas do receptor a2a
CY2011002I1 (el) N-πυρραζολικοι αγωνιστες του α2α υποδοχεα
DE69921351D1 (de) 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii
NO20015779D0 (no) Bradykinin-reseptorantagonister
NO20013997D0 (no) Reseptoranalyse
NO20004503L (no) Vitronectin-reseptor-antagonister
EE200300260A (et) Kondenseeritud puriinderivaadid kui A1 adenosiiniretseptori antagonistid
NO20001515D0 (no) Vitronektin reseptor-antagonist
NO20020979L (no) Selektive A2B-adenosinreseptorantagonister
NO20015662L (no) Oralt aktive A1-adenosinreseptorantagonister
DE69920518D1 (de) Vitronectin rezeptor antagonist
PT1218005E (pt) Antagonistas do receptor de vitronectina
NO20021295D0 (no) Nikotinsyreacetylcholin-reseptor
NO20010620D0 (no) Vitronektinreseptor-antagonister
MA26854A1 (fr) Antagonistes recepteurs de tachykinine non-peptidique
DK1218005T3 (da) Vitronectinreptorantagonister
SE0003996D0 (sv) Receptorantagonister
DK1131291T3 (da) 4-aroyl-piperidin-CCR-3-receptorantagonister III

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees